$750 | Single User
$1500 | Site License
$2250 | Global License

Novacyt SA (ALNOV) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

Published by Global Data: 27 Dec 2018 | 228665 | In Stock

Introduction

Summary

Novacyt SA (Novacyt) is a medical device company that develops and markets medical cytology solutions. The company offers oncology and infectious disease diagnostic products. It also sells diagnostic reagents used in LBC, oncology, microbiology, haematology and serology testing. Novacyt develops proprietary technology platform NOVAPREP, a next generation liquid based cytology solution focused on cancer management. The company’s cytology solution is also used in medical laboratories for diagnoses of diseases based on the study of organs and tissues on a molecular level. It has operations in France and the UK. Novacyt is headquartered in Paris, France.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments

- The report analyzes all pipeline products in development for the company Novacyt SA

- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)

- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date

- The report provides detailed description of products in development, technical specification and functions

- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape

- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio

- To formulate effective Research & Development strategies

- Develop market-entry and market expansion strategies

- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return

- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline

- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage

- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc

- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Table of Contents
for Novacyt SA (ALNOV) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

  • Table of Contents

    Table of Contents 2

    List of Tables 4

    List of Figures 4

    Novacyt SA Company Overview 5

    Novacyt SA Company Snapshot 5

    Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview 5

    Novacyt SA – Pipeline Analysis Overview 8

    Novacyt SA - Key Facts 8

    Novacyt SA - Major Products and Services 9

    Novacyt SA Pipeline Products by Development Stage 10

    Novacyt SA Pipeline Products Overview 12

    Companion Diagnostic Assay- hsa-miR-31-3p - Metastatic Colorectal Cancer 12

    Companion Diagnostic Assay- hsa-miR-31-3p - Metastatic Colorectal Cancer Product Overview 12

    Diagnostic Assay - Aspergillus 13

    Diagnostic Assay - Aspergillus Product Overview 13

    Diagnostic Assay - Pneumocystis 14

    Diagnostic Assay - Pneumocystis Product Overview 14

    Genesig - Cytomegalovirus Test 15

    Genesig - Cytomegalovirus Test Product Overview 15

    Genesig Kit - Human Papillomavirus 14 16

    Genesig Kit - Human Papillomavirus 14 Product Overview 16

    Genesig Kit - Zika Virus 17

    Genesig Kit - Zika Virus Product Overview 17

    Genesig q24 18

    Genesig q24 Product Overview 18

    Multiplex Test - Mosquito-Borne Diseases 19

    Multiplex Test - Mosquito-Borne Diseases Product Overview 19

    Next Generation NOVAPrep 20

    Next Generation NOVAPrep Product Overview 20

    Onconostica 21

    Onconostica Product Overview 21

    Single Nucleotide Polymorphism Assay 22

    Single Nucleotide Polymorphism Assay Product Overview 22

    Novacyt SA - Key Competitors 23

    Novacyt SA - Key Employees 24

    Novacyt SA - Locations And Subsidiaries 25

    Head Office 25

    Other Locations & Subsidiaries 25

    Recent Developments 26

    Novacyt SA, Recent Developments 26

    Jun 05, 2018: Novacyt Launches New Product in Infectious Mononucleosis 26

    Apr 26, 2018: Novacyt Full Year 2017 Results 26

    Mar 22, 2018: Novacyt Signs Assay Development Contract for Diagnosis of Respiratory Infections with GenePOC 31

    Jan 24, 2018: Novacyt Revenues Full Year 2017 31

    Oct 03, 2017: Novacyt Strengthens Primerdesign Business With New Senior Hire 32

    Sep 04, 2017: Novacyt announces further progress in China 33

    Aug 16, 2017: Novacyt Half Year 2017 Results Consolidated sales growth +53% CER Group continues positive outlook for 2017 33

    Jul 20, 2017: Novacyt Revenues Half Year 2017 36

    Apr 27, 2017: Novacyt Full Year 2016 Results Deliver Double Digit Sales Growth 37

    Feb 23, 2017: NOVAprep Regulatory Update in US and ChinaExpands Commercial Reach 39

    Appendix 41

    Methodology 41

    About GlobalData 44

    Contact Us 44

    Disclaimer 44

List Of Tables
in Novacyt SA (ALNOV) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Tables

Novacyt SA Pipeline Products and Ongoing Clinical Trials Overview 5

Novacyt SA Pipeline Products by Equipment Type 6

Novacyt SA Pipeline Products by Indication 7

Novacyt SA, Key Facts 8

Novacyt SA, Major Products and Services 9

Novacyt SA Number of Pipeline Products by Development Stage 10

Novacyt SA Pipeline Products Summary by Development Stage 11

Companion Diagnostic Assay- hsa-miR-31-3p - Metastatic Colorectal Cancer - Product Status 12

Companion Diagnostic Assay- hsa-miR-31-3p - Metastatic Colorectal Cancer - Product Description 12

Diagnostic Assay - Aspergillus - Product Status 13

Diagnostic Assay - Aspergillus - Product Description 13

Diagnostic Assay - Pneumocystis - Product Status 14

Diagnostic Assay - Pneumocystis - Product Description 14

Genesig - Cytomegalovirus Test - Product Status 15

Genesig - Cytomegalovirus Test - Product Description 15

Genesig Kit - Human Papillomavirus 14 - Product Status 16

Genesig Kit - Human Papillomavirus 14 - Product Description 16

Genesig Kit - Zika Virus - Product Status 17

Genesig Kit - Zika Virus - Product Description 17

Genesig q24 - Product Status 18

Genesig q24 - Product Description 18

Multiplex Test - Mosquito-Borne Diseases - Product Status 19

Multiplex Test - Mosquito-Borne Diseases - Product Description 19

Next Generation NOVAPrep - Product Status 20

Next Generation NOVAPrep - Product Description 20

Onconostica - Product Status 21

Onconostica - Product Description 21

Single Nucleotide Polymorphism Assay - Product Status 22

Single Nucleotide Polymorphism Assay - Product Description 22

Novacyt SA, Key Employees 24

Novacyt SA, Subsidiaries 25

Glossary 43

List Of Figures, Charts and Diagrams
in Novacyt SA (ALNOV) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018]

List of Figures

Novacyt SA Pipeline Products by Equipment Type 6

Novacyt SA Pipeline Products by Development Stage 10

Additional Details

Publisher

Global Data

Publisher Information

Reference

228665 | GDME315106PD

Number of Pages

44

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Novacyt SA (ALNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNovacyt SA (Novacyt) is a biotechnology company that develops and markets medical cytology so...
26 Dec 2016 by Global Data USD $250 More Info
Novacyt (ALNOV) - Medical Equipment - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
15 Nov 2016 by Global Data USD $250 More Info
Novacyt (ALNOV) - Medical Equipment - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
22 Aug 2016 by Global Data USD $250 More Info
Novacyt (ALNOV) - Financial and Strategic SWOT Analysis Review
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
11 Jul 2016 by Global Data USD $300 More Info
Novacyt (ALNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
10 May 2016 by Global Data USD $250 More Info
Novacyt (ALNOV) - Financial and Strategic SWOT Analysis Review
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
15 Apr 2016 by Global Data USD $300 More Info
Novacyt (ALNOV) - Medical Equipment - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
15 Apr 2016 by Global Data USD $250 More Info
Novacyt (ALNOV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
15 Mar 2016 by Global Data USD $250 More Info
Novacyt - Medical Equipment - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
25 Feb 2016 by Global Data USD $250 More Info
Novacyt - Medical Equipment - Deals and Alliances Profile
SummaryNovacyt is a biotechnology company that develops and markets medical cytology solutions. The ...
23 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Novacyt SA (ALNOV) - Product Pipeline Analysis, 2018 Update [Report Updated: 27-12-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data